Razumab 0.5mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Ranibizumab (0.5mg)
Overview Razumab 0.5mg Injection
Diabetic retinopathy, macular degeneration, and macular edema are treated with a 0.5mg injection of Razumab. This medication targets abnormal blood vessel growth and leakage in the eye, a leading cause of vision impairment. Administration is strictly via intraocular injection by an ophthalmologist; self-injection is prohibited. Potential side effects include conjunctival bleeding, ocular pain, floaters, elevated intraocular pressure, and eye inflammation. Persistent side effects or any concerning symptoms warrant immediate medical attention. Driving is discouraged following injection due to potential visual disturbances.
Uses of Razumab 0.5mg Injection
Eye conditions associated with diabetes, age-related macular degeneration (wet type), and retinal vein occlusion-related macular swelling.
Major Benefits of Razumab 0.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Razumab 0.5mg Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Razumab 0.5mg Injection:
Administering this medication will be handled by your physician or their registered nurse; self-medication is strictly prohibited.
How Razumab 0.5mg Injection works:
Eye injections of Razumab 0.5mg inhibit the formation of new blood vessels. This anti-angiogenic effect is achieved by targeting vascular endothelial growth factor (VEGF), a protein crucial for blood vessel development, thus preventing the abnormal blood vessel growth and leakage in the eye(s) which can impair vision.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Razumab 0.5mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Razumab 0.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingSAFE IF PRESCRIBED
The administration of 0.5mg Razumab Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Following administration of Razumab 0.5mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneySAFE IF PRESCRIBED
Employing Razumab 0.5mg Injection in individuals with kidney impairment appears to present a low risk. Existing evidence indicates dose modification of Razumab 0.5mg Injection may be unnecessary for this population; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Razumab 0.5mg Injection in patients with hepatic impairment is likely safe, with current evidence indicating that dose modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Razumab 0.5mg Injection :
Omit a Razumab 0.5mg Injection dose? Seek medical advice immediately.
Facts to Know About Razumab 0.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Actions | Anti-VEGF therapy for age-related macular degeneration |
3,018 People bought this recently